NCT01787825View on ClinicalTrials.gov

Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

February 29, 2016

Conditions
Intestinal DiseaseInflammatory Bowel DiseaseCrohn DiseaseUlcerCeliac Disease
Interventions
DEVICE

PillCam SB2 capsule

Capsule Endoscopy system

DEVICE

CapsoCam SV-1

Capsule endoscopy

Trial Locations (7)

29425

Medical University of South Carolina, Charleston

33173

Gastro Health, Miami

38138

Ziad Younes, MD, Germantown

75390

UT Southwestern Medical Center, Dallas

85259

Shabana F. Pasha, MD, Scottsdale

01655

University of Massachusetts, Worcester, Worcester

V6Z 2K5

Pacific Gastroenterology Associates GI Research Institute, Vancouver

Sponsors

Lead Sponsor

Capso Vision, Inc.
All Listed Sponsors
lead

Capso Vision, Inc.

INDUSTRY

NCT01787825 - Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease | Biotech Hunter | Biotech Hunter